United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

CMS Appeals Humana v. Becerra

The Northern District of Texas' original ruling vacated CMS's 2023 Final Rule—which had eliminated use of the FFS adjuster in RADV audit findings and expressly incorporated extrapolation into its regulations...

United States Healthcare

CM

Crowell & Moring LLP

2026 Physician Fee Schedule Final Rule: FMV And Bona Fide Service Fee Implications

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule final rule for calendar year 2026 (Final Rule).

United States Healthcare

AC

Ankura Consulting Group LLC

Genesis Mission Seeks To Bolster Scientific Discovery, National Security, Energy Dominance

The Genesis Mission, launched by executive order (EO) on Nov. 24, 2025, is a national initiative that aims to accelerate scientific discovery by leveraging various forms of artificial intelligence (AI

United States Healthcare

HK

Holland & Knight

State PBM Oversight Has Been Growing But Enforcement Still Falls Short: Why Pharmacies Must Step Up

States across the country have made a genuine effort to rein in the conduct of Pharmacy Benefit Managers (PBMs).

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Bridging The Gap: Maine's New Law Empowers Pharmacies And Pharmacists To Improve Rural Access To Medications

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Kentucky Pharmacies: Prepare For USP Changes In The New Year

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?

United States Healthcare

AP

Arnold & Porter

BsUFA IV Is Coming: FDA Calls For Public Input

United States Healthcare

HP

Hyman, Phelps, & McNamara

Manatt Telehealth Policy Tracker: Tracking Ongoing Federal And State Telehealth Policy Changes

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

"Implications" All The Way Down: Third Circuit Ruling Brings More "Implicit Misrepresentations" Within Scope Of Healthcare Fraud

United States Healthcare

AP

Arnold & Porter

Senators Introduce Better Food Disclosure Act

United States Healthcare

SH

Shook, Hardy & Bacon

CMS Releases CY 2026 Hospital OPPS And Ambulatory Surgical Center Final Rule

United States Healthcare

HK

Holland & Knight

Medical/Commercial Activities And Interactions: Benchmarking And Compliance Insights

United States Healthcare

PB

Porzio, Bromberg & Newman

Trump To Impose 100% Tariff On Some Imported Prescription Drugs

United States Healthcare

HB

Hall Benefits Law

California Air Resources Board Publishes Draft SB 261 Guidance

United States Commercial

RG

Ropes & Gray LLP

Banking Industry Outlook: U.S. Banking M&A Surge Arrives In Q3

United States Compliance

AC

Ankura Consulting Group LLC

Why Direct Student-Athlete Payments Create An Immigration Crisis For Universities

United States Immigration

Gs

Green and Spiegel

From Conflict To Clarity: Why The ADR Experience Matters In Successful Resolution

United States Litigation

J

JAMS

Early Mediation: Is Your Case A Likely Candidate?

United States Litigation

J

JAMS

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

2026 Physician Fee Schedule Final Rule: FMV And Bona Fide Service Fee Implications

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule final rule for calendar year 2026 (Final Rule).

United States Healthcare

AC

Ankura Consulting Group LLC

ACA Files Suit Challenging Colorado Law That Omits Medical Debts From Credit Reports

The trade group representing debt collection agencies, creditors, debt buyers, collection attorneys, and debt collection industry service providers has filed suit...

United States Finance

BS

Ballard Spahr LLP

State PBM Oversight Has Been Growing But Enforcement Still Falls Short: Why Pharmacies Must Step Up

States across the country have made a genuine effort to rein in the conduct of Pharmacy Benefit Managers (PBMs).

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Bridging The Gap: Maine's New Law Empowers Pharmacies And Pharmacists To Improve Rural Access To Medications

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Kentucky Pharmacies: Prepare For USP Changes In The New Year

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

D. Mass. Patent Litigation Update: October 2025

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?

United States Healthcare

AP

Arnold & Porter

BsUFA IV Is Coming: FDA Calls For Public Input

United States Healthcare

HP

Hyman, Phelps, & McNamara

"Implications" All The Way Down: Third Circuit Ruling Brings More "Implicit Misrepresentations" Within Scope Of Healthcare Fraud

United States Healthcare

AP

Arnold & Porter

See more

Life Sciences, Biotechnology & Nanotechnology

Genesis Mission Seeks To Bolster Scientific Discovery, National Security, Energy Dominance

The Genesis Mission, launched by executive order (EO) on Nov. 24, 2025, is a national initiative that aims to accelerate scientific discovery by leveraging various forms of artificial intelligence (AI

United States Healthcare

HK

Holland & Knight

Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?

On 23 October 2025, Advocate General ("AG") Emiliou delivered his opinion in Case C-118/24: Laboratoires Eurogenerics and Theramex France

United States Healthcare

AP

Arnold & Porter

BsUFA IV Is Coming: FDA Calls For Public Input

FDA has announced a public meeting and request for comment on proposed recommendations for the next reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years 2028 through 2032.

United States Healthcare

HP

Hyman, Phelps, & McNamara

CMS Releases CY 2026 Hospital OPPS And Ambulatory Surgical Center Final Rule

United States Healthcare

HK

Holland & Knight

Medical/Commercial Activities And Interactions: Benchmarking And Compliance Insights

United States Healthcare

PB

Porzio, Bromberg & Newman

Virtual And Digital Health Digest (October/November 2025)

Worldwide Healthcare

AP

Arnold & Porter

Formycon Announces New Dupilumab Biosimilar Candidate

United States Healthcare

GP

Goodwin Procter LLP

Increased Federal Enforcement Of Illicit Ends Products

Worldwide Healthcare

BI

Buchanan Ingersoll & Rooney PC

European Commission Approves Alvotech's And Teva's Denosumab Biosimilars

European Union Healthcare

GP

Goodwin Procter LLP

See more

Healthcare

Estrategia de Inmigración para Instituciones de Salud de los Estados Unidos De Riesgo Legal a Ventaja Estratégica

A medida que el número de pacientes aumenta rápidamente, la necesidad de profesionales de la salud, incluyendo médicos, enfermeras y enfermeras de práctica avanzada, está creciendo de manera dramática.

United States Immigration

AL

Akalan Law Firm

CMS Appeals Humana v. Becerra

The Northern District of Texas' original ruling vacated CMS's 2023 Final Rule—which had eliminated use of the FFS adjuster in RADV audit findings and expressly incorporated extrapolation into its regulations...

United States Healthcare

CM

Crowell & Moring LLP

2026 Physician Fee Schedule Final Rule: FMV And Bona Fide Service Fee Implications

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule final rule for calendar year 2026 (Final Rule).

United States Healthcare

AC

Ankura Consulting Group LLC

Genesis Mission Seeks To Bolster Scientific Discovery, National Security, Energy Dominance

United States Healthcare

HK

Holland & Knight

ACA Files Suit Challenging Colorado Law That Omits Medical Debts From Credit Reports

United States Finance

BS

Ballard Spahr LLP

Bridging The Gap: Maine's New Law Empowers Pharmacies And Pharmacists To Improve Rural Access To Medications

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Kentucky Pharmacies: Prepare For USP Changes In The New Year

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Manatt Telehealth Policy Tracker: Tracking Ongoing Federal And State Telehealth Policy Changes

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

"Implications" All The Way Down: Third Circuit Ruling Brings More "Implicit Misrepresentations" Within Scope Of Healthcare Fraud

United States Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

The Big, Beautiful Webinar Series: Strategic Planning For Post-Acute/LTC Providers (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More